ZELBORAF (vemurafenib) - Risk of Radiation Sensitization or Radiation Recall Reaction
Issued December 22, 2015
Issue
Cases of radiation sensitization and cases of radiation recall reactions have been reported in patients treated with radiation prior to, during, or following ZELBORAF (vemurafenib) treatment.
Hazard description
Product safety
Get notified of similar recallsEnter your email to receive alerts when new recalls are issued by the same agency.
Subscribed. You'll get an email when new recalls are issued.
RecallTracker